NCT04284774: A trial that was reported late by National Cancer Institute (NCI)
This trial has reported, although it was 8 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT04284774 |
|---|---|
| Title | NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice)- Phase 2 Subprotocol of Tipifarnib in Patients With Tumors Harboring HRAS Genomic Alterations |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Oct. 13, 2020 |
| Completion date | March 31, 2024 |
| Required reporting date | March 31, 2025, midnight |
| Actual reporting date | April 8, 2025 |
| Date last checked at ClinicalTrials.gov | June 9, 2025 |
| Days late | 8 |